This report contains market size and forecasts of Retinal Disorder Drug in Global, including the following market information:
Global Retinal Disorder Drug Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Retinal Disorder Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Glaucoma Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Retinal Disorder Drug include Novartis Allergan, Roche, Valeant, Regeneron, Alcon inc., Pfizer inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Bausch and Lomb Incorporated, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Disorder Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Disorder Drug Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Type, 2022 (%)
Glaucoma
Dry Eye Syndrome
Global Retinal Disorder Drug Market, by Distribution Channel, 2018-2023, 2023-2030 ($ millions)
Global Retinal Disorder Drug Market Segment Percentages, by Distribution Channel, 2022 (%)
Hospital Pharmacy
Drugs Store
Online Pharmacies
Global Retinal Disorder Drug Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Retinal Disorder Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Disorder Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Retinal Disorder Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis Allergan
Roche
Valeant
Regeneron
Alcon inc.
Pfizer inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Bausch and Lomb Incorporated
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Disorder Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Retinal Disorder Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Disorder Drug Overall Market Size
2.1 Global Retinal Disorder Drug Market Size: 2022 VS 2030
2.2 Global Retinal Disorder Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Retinal Disorder Drug Players in Global Market
3.2 Top Global Retinal Disorder Drug Companies Ranked by Revenue
3.3 Global Retinal Disorder Drug Revenue by Companies
3.4 Top 3 and Top 5 Retinal Disorder Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Retinal Disorder Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Disorder Drug Players in Global Market
3.6.1 List of Global Tier 1 Retinal Disorder Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Retinal Disorder Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Retinal Disorder Drug Market Size Markets, 2022 & 2030
4.1.2 Glaucoma
4.1.3 Dry Eye Syndrome
4.2 By Type - Global Retinal Disorder Drug Revenue & Forecasts
4.2.1 By Type - Global Retinal Disorder Drug Revenue, 2018-2023
4.2.2 By Type - Global Retinal Disorder Drug Revenue, 2023-2030
4.2.3 By Type - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Disorder Drug Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Drugs Store
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global Retinal Disorder Drug Revenue & Forecasts
5.2.1 By Distribution Channel - Global Retinal Disorder Drug Revenue, 2018-2023
5.2.2 By Distribution Channel - Global Retinal Disorder Drug Revenue, 2023-2030
5.2.3 By Distribution Channel - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Retinal Disorder Drug Market Size, 2022 & 2030
6.2 By Region - Global Retinal Disorder Drug Revenue & Forecasts
6.2.1 By Region - Global Retinal Disorder Drug Revenue, 2018-2023
6.2.2 By Region - Global Retinal Disorder Drug Revenue, 2023-2030
6.2.3 By Region - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Retinal Disorder Drug Revenue, 2018-2030
6.3.2 US Retinal Disorder Drug Market Size, 2018-2030
6.3.3 Canada Retinal Disorder Drug Market Size, 2018-2030
6.3.4 Mexico Retinal Disorder Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Retinal Disorder Drug Revenue, 2018-2030
6.4.2 Germany Retinal Disorder Drug Market Size, 2018-2030
6.4.3 France Retinal Disorder Drug Market Size, 2018-2030
6.4.4 U.K. Retinal Disorder Drug Market Size, 2018-2030
6.4.5 Italy Retinal Disorder Drug Market Size, 2018-2030
6.4.6 Russia Retinal Disorder Drug Market Size, 2018-2030
6.4.7 Nordic Countries Retinal Disorder Drug Market Size, 2018-2030
6.4.8 Benelux Retinal Disorder Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Retinal Disorder Drug Revenue, 2018-2030
6.5.2 China Retinal Disorder Drug Market Size, 2018-2030
6.5.3 Japan Retinal Disorder Drug Market Size, 2018-2030
6.5.4 South Korea Retinal Disorder Drug Market Size, 2018-2030
6.5.5 Southeast Asia Retinal Disorder Drug Market Size, 2018-2030
6.5.6 India Retinal Disorder Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Retinal Disorder Drug Revenue, 2018-2030
6.6.2 Brazil Retinal Disorder Drug Market Size, 2018-2030
6.6.3 Argentina Retinal Disorder Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Retinal Disorder Drug Revenue, 2018-2030
6.7.2 Turkey Retinal Disorder Drug Market Size, 2018-2030
6.7.3 Israel Retinal Disorder Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Retinal Disorder Drug Market Size, 2018-2030
6.7.5 UAE Retinal Disorder Drug Market Size, 2018-2030
7 Players Profiles
7.1 Novartis Allergan
7.1.1 Novartis Allergan Corporate Summary
7.1.2 Novartis Allergan Business Overview
7.1.3 Novartis Allergan Retinal Disorder Drug Major Product Offerings
7.1.4 Novartis Allergan Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.1.5 Novartis Allergan Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Retinal Disorder Drug Major Product Offerings
7.2.4 Roche Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.2.5 Roche Key News
7.3 Valeant
7.3.1 Valeant Corporate Summary
7.3.2 Valeant Business Overview
7.3.3 Valeant Retinal Disorder Drug Major Product Offerings
7.3.4 Valeant Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.3.5 Valeant Key News
7.4 Regeneron
7.4.1 Regeneron Corporate Summary
7.4.2 Regeneron Business Overview
7.4.3 Regeneron Retinal Disorder Drug Major Product Offerings
7.4.4 Regeneron Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.4.5 Regeneron Key News
7.5 Alcon inc.
7.5.1 Alcon inc. Corporate Summary
7.5.2 Alcon inc. Business Overview
7.5.3 Alcon inc. Retinal Disorder Drug Major Product Offerings
7.5.4 Alcon inc. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.5.5 Alcon inc. Key News
7.6 Pfizer inc.
7.6.1 Pfizer inc. Corporate Summary
7.6.2 Pfizer inc. Business Overview
7.6.3 Pfizer inc. Retinal Disorder Drug Major Product Offerings
7.6.4 Pfizer inc. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.6.5 Pfizer inc. Key News
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
7.7.2 Sun Pharmaceutical Industries Ltd. Business Overview
7.7.3 Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.7.5 Sun Pharmaceutical Industries Ltd. Key News
7.8 Teva Pharmaceutical Industries Ltd.
7.8.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.8.3 Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Major Product Offerings
7.8.4 Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.8.5 Teva Pharmaceutical Industries Ltd. Key News
7.9 Bausch and Lomb Incorporated
7.9.1 Bausch and Lomb Incorporated Corporate Summary
7.9.2 Bausch and Lomb Incorporated Business Overview
7.9.3 Bausch and Lomb Incorporated Retinal Disorder Drug Major Product Offerings
7.9.4 Bausch and Lomb Incorporated Retinal Disorder Drug Revenue in Global Market (2018-2023)
7.9.5 Bausch and Lomb Incorporated Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Retinal Disorder Drug Market Opportunities & Trends in Global Market
Table 2. Retinal Disorder Drug Market Drivers in Global Market
Table 3. Retinal Disorder Drug Market Restraints in Global Market
Table 4. Key Players of Retinal Disorder Drug in Global Market
Table 5. Top Retinal Disorder Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Retinal Disorder Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Retinal Disorder Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Retinal Disorder Drug Product Type
Table 9. List of Global Tier 1 Retinal Disorder Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Disorder Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Retinal Disorder Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Retinal Disorder Drug Revenue in Global (US$, Mn), 2023-2030
Table 14. By Distribution Channel ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Distribution Channel - Retinal Disorder Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Distribution Channel - Retinal Disorder Drug Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Retinal Disorder Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Retinal Disorder Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Retinal Disorder Drug Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Retinal Disorder Drug Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Retinal Disorder Drug Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Retinal Disorder Drug Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Retinal Disorder Drug Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Retinal Disorder Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Retinal Disorder Drug Revenue, (US$, Mn), 2023-2030
Table 30. Novartis Allergan Corporate Summary
Table 31. Novartis Allergan Retinal Disorder Drug Product Offerings
Table 32. Novartis Allergan Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 33. Roche Corporate Summary
Table 34. Roche Retinal Disorder Drug Product Offerings
Table 35. Roche Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 36. Valeant Corporate Summary
Table 37. Valeant Retinal Disorder Drug Product Offerings
Table 38. Valeant Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 39. Regeneron Corporate Summary
Table 40. Regeneron Retinal Disorder Drug Product Offerings
Table 41. Regeneron Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 42. Alcon inc. Corporate Summary
Table 43. Alcon inc. Retinal Disorder Drug Product Offerings
Table 44. Alcon inc. Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 45. Pfizer inc. Corporate Summary
Table 46. Pfizer inc. Retinal Disorder Drug Product Offerings
Table 47. Pfizer inc. Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 48. Sun Pharmaceutical Industries Ltd. Corporate Summary
Table 49. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Product Offerings
Table 50. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 51. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 52. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Product Offerings
Table 53. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
Table 54. Bausch and Lomb Incorporated Corporate Summary
Table 55. Bausch and Lomb Incorporated Retinal Disorder Drug Product Offerings
Table 56. Bausch and Lomb Incorporated Retinal Disorder Drug Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Retinal Disorder Drug Segment by Type in 2022
Figure 2. Retinal Disorder Drug Segment by Distribution Channel in 2022
Figure 3. Global Retinal Disorder Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Retinal Disorder Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Retinal Disorder Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Disorder Drug Revenue in 2022
Figure 8. By Type - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 9. By Distribution Channel - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 10. By Region - Global Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 11. By Country - North America Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 12. US Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 16. Germany Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 17. France Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 24. China Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 28. India Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 30. Brazil Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Retinal Disorder Drug Revenue Market Share, 2018-2030
Figure 33. Turkey Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Retinal Disorder Drug Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis Allergan Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Roche Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Valeant Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Regeneron Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Alcon inc. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer inc. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sun Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Pharmaceutical Industries Ltd. Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bausch and Lomb Incorporated Retinal Disorder Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
